The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma

BACKGROUND: The serine peptidase inhibitor Kazal type 13 (SPINK13) gene has tumor suppressor activity, but its role in renal cell carcinoma (RCC) remains unknown. This study aimed to investigate mRNA expression of SPINK13 in clear cell renal cell carcinoma (CCRCC) in human tissue and to use bioinfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wen-Hao, Shi, Shen-Nan, Wang, Jun, Xu, Yue, Tian, Xi, Wan, Fang-Ning, Cao, Da-Long, Qu, Yuan-Yuan, Zhang, Hai-Liang, Ye, Ding-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926094/
https://www.ncbi.nlm.nih.gov/pubmed/31825950
http://dx.doi.org/10.12659/MSM.917754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926094/
https://www.ncbi.nlm.nih.gov/pubmed/31825950
http://dx.doi.org/10.12659/MSM.917754

Ejemplares similares